Kiora Pharmaceuticals, Inc. (KPRX:NASDAQ) closed at $2.47 on October 13, 2026, down 3.52% on the day. The stock trades 15.1% below its 52-week high of $2.91 and 39.9% above its 52-week low of $1.77. Over the past year, it lost 9.9%. Kiora Pharmaceuticals, Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -2.76% | -6.79% | -3.14% | -1.98% | -9.85% |
In 252 trading sessions since October 13, 2025, KPRX closed higher on 108 days (43%). Its best day was April 8, 2026 (+32.41%) and its worst was April 9, 2026 (-13.29%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 2 times.
Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. The products pipeline of the company includes KIO-101, KIO-201, KIO-301, and KIO-102.
Find more stocks like KPRX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.